Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias - Triple-labeling immunofluorescence study

Acta Neuropathologica

Volumn 102, Issue 2, 2001, Pages 149-152

  Andy, P ^a   Garcia Martinez, J ^a,b   Lee, G ^a   Gonzalez, H ^a   Jones, C W ^a   Davis, M E ^a  

^a California Institute of Technology   (United States)

^b UNIVERSITY OF ALICANTE   (Spain)

Author keywords

CAG repeat; Immunofluorescence; Intranuclear inclusion; Pons; Triple labeling

Indexed keywords

ADENINE; ATAXIN 2; ATAXIN 3; CYTOSINE; GENE PRODUCT; GUANINE; POLYGLUTAMINE; TATA BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BRAIN ATROPHY; BRAIN NERVE CELL; CELL NUCLEUS; CELL NUCLEUS INCLUSION BODY; CLINICAL ARTICLE; CONTROLLED STUDY; DENTATE NUCLEUS; DISEASE CLASSIFICATION; GLOBUS PALLIDUS; HEREDITARY ATAXIA; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; NERVE CELL; PONS; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN TRANSPORT; RED NUCLEUS; SPINOCEREBELLAR DEGENERATION; SUBTHALAMIC NUCLEUS; TRINUCLEOTIDE REPEAT;

CELL NUCLEUS; DNA-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; NERVE TISSUE PROTEINS; NEURONS; NUCLEAR PROTEINS; PEPTIDES; PONS; PROTEINS; REPRESSOR PROTEINS; SPINOCEREBELLAR DEGENERATIONS; TATA-BOX BINDING PROTEIN; TRANSCRIPTION FACTORS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 0034887539     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010100364     Document Type: Article

References (20)

1. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: Correlation between the density of inclusions and IT15 CAG triplet repeat length
2. Nuclear inclusions in spinocerebellar ataxia type 1
3. Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains
4. Hereditary dentatorubral-pallidoluysian atrophy: Detection of widespread ubiquitinated neuronal and glial intranuclear inclusions in the brains
5. Spinocerebellar ataxia type 7 (SCA7): A neurodegenerative disorder with neuronal intranuclear inclusions
6. Expression of ataxin-2 in brains from normal individuals and patients with Alzheimer's disease and spinocerebellar ataxia 2
7. Autosomal dominant spinocerebellar degenerations. Clinical, pathological and genetic correlations
8. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1
9. Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice
10. Neuronal intranuclear inclusions in spinocerebellar ataxia type 2: Triple-labeling immunofluorescent study
11. Neuronal intranuclear inclusions in spinocerebellar ataxia type 2
12. A monoclonal antibody raised against amino acids 497-507 of the human estrogen receptor recognizes human ataxin-2
13. Ataxin 1 and ataxin 3 in neuronal intranuclear inclusion disease
14. Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse
15. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3
16. Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation
17. Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA
18. Neuronal intranuclear hyaline inclusion disease with polyglutamine immunoreactive inclusions
19. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias
20. Dual enhancement of double immunofluorescent signals by CARD: Participation of ubiquitin during formation of neurofibrillary tangles